BlackRock’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.5M | Buy |
|
|||||
|
2025
Q1 | $2.69M | Buy |
|
|||||
|
2024
Q4 | $613K | Sell |
|
|||||
|
2024
Q3 | $214K | Buy |
|
|||||
|
2024
Q2 | $240K | Buy |
|
|||||
|
2024
Q1 | $124K | Sell |
|
|||||
|
2023
Q4 | $64.3K | Sell |
|
|||||
|
2023
Q3 | $57.8K | Sell |
|
|||||
|
2023
Q2 | $86.6K | Sell |
|
|||||
|
2023
Q1 | $116K | Buy |
|
|||||
|
2022
Q4 | $97.4K | Buy |
|
|||||
|
2022
Q3 | $105K | Sell |
|
|||||
|
2022
Q2 | $113K | Sell |
|
|||||
|
2022
Q1 | $200K | Sell |
|
|||||
|
2021
Q4 | $271K | Sell |
|
|||||
|
2021
Q3 | $306K | Buy |
|
|||||
|
2021
Q2 | $391K | Sell |
|
|||||
|
2021
Q1 | $2.99M | Buy |
|
|||||
|
2020
Q4 | $4.4M | Buy |
|
|||||
|
2020
Q3 | $1.55M | Sell |
|
|||||
|
2020
Q2 | $2.71M | Buy |
|
|||||
|
2020
Q1 | $17K | Buy |
|
|||||
|
2019
Q4 | $3K | Buy |
|
|||||
|
2019
Q3 | $2K | Buy |
|
|||||
|
2019
Q2 | $2K | Sell |
|
|||||
|
2019
Q1 | $19K | Buy |
|
|||||
|
2018
Q4 | $72K | Buy |
|
|||||
|
2018
Q3 | $61K | Buy |
|
|||||
|
2018
Q2 | $74K | Buy |
|
|||||
|
2018
Q1 | $9K | Sell |
|
|||||
|
2017
Q4 | $10K | Buy |
|
|||||
|
2017
Q3 | $10K | Buy |
|
|||||
|
2017
Q2 | $6K | Sell |
|
|||||
|
2017
Q1 | $45K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1K | Buy |
|